Clinical Trials Directory

Trials / Unknown

UnknownNCT05208827

Vitamin D Supplementation for the Prevention of GDM

A Multicenter Randomized Controlled Study of Vitamin D Supplementation in Pregnant Women for the Prevention of Gestational Diabetes

Status
Unknown
Phase
EARLY_Phase 1
Study type
Interventional
Enrollment
1,600 (estimated)
Sponsor
Women's Hospital School Of Medicine Zhejiang University · Academic / Other
Sex
Female
Age
18 Years – 45 Years
Healthy volunteers
Accepted

Summary

This study was a double-blind multicenter randomized controlled study.

Detailed description

This study intends to adopt a randomized controlled study design, and randomly divide pregnant women at high risk of GDM into intervention group (VitD3:1600 IU/ day) (n=800) and control group (placebo:2 tablets/day) (n=800) until the end of delivery. The risk of GDM in pregnant women of the two groups was compared, the preventive effect of high-dose VitD supplementation during pregnancy on different subtypes of GDM was determined, and the effects of VitD supplementation on VitD nutritional status during pregnancy and birth outcome and health of offspring were explored, so as to provide evidence-based basis for rational VitD supplementation during pregnancy.

Conditions

Interventions

TypeNameDescription
DRUGVitamin D3Participants began to take medication at 12 weeks of gestation, and participants in the second trimester began to take medication at the time point of enrollment.The dosage is 2 tablets per day, taken orally for 12 weeks.The drug in the intervention group was fat-soluble vitamin D3, which was produced by Sinopril Holding Starfish Pharmaceutical (Xiamen) Co., LTD. Each tablet contained 800 units of vitamin D3, vegetable oil and starch as auxiliary material.
DRUGThe placebo(not contain vitamin D)Pills that looked, colored and tasted like vitamin D in the control group, but contained only starch and vegetable oil and no vitamin D.

Timeline

Start date
2022-01-01
Primary completion
2025-01-01
Completion
2025-01-01
First posted
2022-01-26
Last updated
2022-01-26

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05208827. Inclusion in this directory is not an endorsement.